SIRTURO
- Product NDC
- 59676-702
- 11-digit product format
- 596760702
- Labeler code
- 59676
- Product ID
- 59676-702_415acee9-3121-56fb-e063-6394a90a9d83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bedaquiline Fumarate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Janssen Products, LP
- Application
- NDA204384
- Marketing category
- NDA
- Marketing start
- 2020-05-27
- Substance
- BEDAQUILINE FUMARATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Diarylquinoline Antimycobacterial [EPC], Diarylquinolines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SIRTURO
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEDAQUILINE FUMARATE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | P04QX2C1A5 |
| Rxcui | 1364509, 1364515, 2373939, 2373941 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59676-702-60 | SIRTURO | 60 in 1 BOTTLE | TABLET | 60 | | 33 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Bedaquiline Fumarate | ACTIVE INGREDIENT | P04QX2C1A5 | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| Bedaquiline | ACTIVE MOIETY | 78846I289Y | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| hypromellose 2910 (15 mPa.s) | INACTIVE INGREDIENT | 36SFW2JZ0W | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59676-702 | SIRTURO (BEDAQUILINE FUMARATE) TABLET [JANSSEN PRODUCTS, LP] | 28 | Current NDC, Legacy NDC, 1 package rows | 20240802_1534c9ae-4948-4cf4-9f66-222a99db6d0e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59676-702-60 | 59676070260 | 60 TABLET in 1 BOTTLE (59676-702-60) | 60 tablet | 2020-05-27 | 0000-00-00 | No | No | Current |